RGT argent biopharma limited

Ann: Operational and Clinical Development Update, page-4

  1. 15,656 Posts.
    lightbulb Created with Sketch. 2807
    Therein lies the problem perhaps.

    RGT has changed the focus of its business model maybe 6 times in the last 15 years. All that has done is dilute its ability to maintain momentum.

    It was initially a supplier of materials to the EU and is now basically a herbal medicine company having also off-loaded production and distribution to other companies. So, an empty shell really.

    Credibility has gone, and any chance of recovery gone as well.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.5¢
Change
-0.004(5.06%)
Mkt cap ! $5.413M
Open High Low Value Volume
7.7¢ 7.7¢ 7.5¢ $1.541K 20.01K

Buyers (Bids)

No. Vol. Price($)
1 22550 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 8000 1
View Market Depth
Last trade - 14.27pm 25/07/2025 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.